Navigation Links
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Date:1/24/2013

compared to 38 days at both September 30, 2012 and December 31, 2011.

The Company's investor conference call will be webcast on January 25 at 9:00 am ET.  Management's commentary and presentation slides will be available through www.covance.com

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues of approximately $2.2 billion, global operations in more than 30 countries, and more than 11,750 employees worldwide.  Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.  These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss or delay of large studies, risks associated with acquisitions and investments, the Company's ability to increase order volume, the pace of translation of orders into revenue in late-stage develo
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)...  TransCelerate BioPharma Inc. ("TransCelerate") announces the ... Risk-Based Monitoring (RBM), " Evaluating Source Data ... Clinical Trials ," in the Drug Information ...  (TIRS) journal. Developed by TransCelerate,s 19 member ... examines the value of Source Data Verification ...
(Date:11/18/2014)... FT LAUDERDALE, Fla. , November 18, 2014 ... ), a leading solution provider of access control ... the company has joined the Green Rush Alliance ... solutions to  customers and businesses in the Cannabis ... products and services to medical marijuana dispensaries, retailers ...
(Date:11/18/2014)...  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer") ... Commission (the "EC") to extend the deadline for the ... a limited number of days in order to provide ... Deadline extensions are not uncommon in such in-depth investigations.  ... to facilitate their review of the pending transaction and ...
Breaking Medicine Technology:TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3Profile Solutions, Inc Joins the Green Rush Alliance 2Profile Solutions, Inc Joins the Green Rush Alliance 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5
... from a Phase III,clinical trial evaluating the efficacy ... the treatment of postmenopausal osteoporosis were,presented at the ... Annual Meeting. In the non-inferiority study comparing risedronate ... [Actonel(R) (risedronate sodium,tablets)] increases in bone mineral density ...
... Medical,Technologies, Inc. (Nasdaq: RMTI ), a ... specialty pharmaceuticals focused on the end-,stage-renal-disease market ... in its Phase IIb dose-ranging study for ... drug. The Phase IIb dose-ranging study ...
Cached Medicine Technology:New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 2New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 3New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 4New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 5New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 6Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 2Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 3Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study 4
(Date:11/21/2014)... Thompson HealthDay Reporter THURSDAY, ... into the wall of a still-beating heart has the potential ... according to a new study. Heart patients who received ... able to walk hundreds of feet farther during a six-minute ... chief of the cardiovascular division at Washington University School of ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Kidney donation is one of ... And now a new study finds that former donors who ... from policies that give them priority on the transplant waiting ... the 16,900 kidney transplants that took place in the United ... study researchers. At the time of donation, most ...
(Date:11/18/2014)... Hawthorne, CA (PRWEB) November 18, 2014 ... implants more affordable for patients. Nearly 70 percent of Americans ... those over the age of 74, 25 percent are missing ... tooth replacement options are available, but only one offers a ... teeth. , This special includes a complimentary consultation that ...
(Date:11/18/2014)... TUESDAY, Nov. 18, 2014 (HealthDay News) -- Routine screening ... who have no symptoms but are at high risk ... Researchers found the screenings do not help prevent ... the hospital for unstable angina (chest pain that occurs ... Properly controlling diabetes is still the best way to ...
(Date:11/18/2014)... 18, 2014 Global Partnership ... the telehealth platform to bring quality healthcare to ... passion, GPT created Global Partnership for TeleHealth Missions ... existing telehealth network. GPTM focuses specifically on ... and disaster relief organizations. , Michael ...
Breaking Medicine News(10 mins):Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3Health News:Study Supports Giving Kidney Donors Priority When They Need a Kidney 2Health News:Hawthorne Dentist, Dr. Yashari, is Now Making Dental Implants More Affordable for Patients 2Health News:Study Finds No Added Benefit From Routine Heart Scans for Diabetics 2Health News:Study Finds No Added Benefit From Routine Heart Scans for Diabetics 3Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2
... the NHS on April 1. Dentists in England and Wales ... April 1st. Several Cumbrian practices have // already opted out. ... when leaving the NHS. ,But now due to ... days notice. The North Cumbria Primary Care Trusts (PCTs) cannot ...
... Uttar Pradesh rural doctors are angry at the village heads, ... medics. The doctors have threatened to go on an indefinite ... health secretary last week directed district chief medical officers to ... community health centres with the help of village chiefs or ...
... boy battling life with life support should be kept alive, ... High Court. // This is a landmark judgement, especially, since ... support, to allow him to die, rather than prolong a ... ,The Judge’s ruling disallowed the NHS trust to sweep aside ...
... administered a potentially deadly radiation overdose .Lisa Norris, is trying ... treatment. // She has re-joined school and will be celebrating ... Girvan in Ayrshire, in a case of human error, was ... Centre in Glasgow. She was being treated for brain tumor. ...
... XR drug for attention deficit hyperactivity disorder (ADHD) needs to ... the US FDA regulators. // ,It has ... about the side effects of the drug such as hallucinations ... with no identifiable risk factors. The FDA had prepared a ...
... Amanda Walmsley who worked in developing a vaccine against the ... flu in tomatoes. // ,The tomato bird flu ... tomatoes which are the storehouse of vaccines would be fed ... a very simple procedure the fruits are harvested, freeze-dried and ...
Cached Medicine News:
... The HARMONY Cardiology Module incorporates an ... with Open Systems Technology mandated by ... protocols. Allowing for easy access to ... communications, HARMONY provides new efficiency with ...
... VitalWorks' practice management systems have brought cutting-edge ... bases in the world. Today, Intuition PM ... in a friendly, intuitive manner. Automate patient ... expedite in-office patient processing through wireless hand-held ...
... Total Practice Partner is a ... manage all of the mission-critical functions ... Partner includes Patient Records, one of ... systems, Appointment Scheduler, a sophisticated multi-clinic ...
... EpicCare is the most successful EMR ... proven scalability facilitate improvements that deliver ... service improvements from our clients abound, ... increasing patient satisfaction. They have realized ...
Medicine Products: